News

11/03/2016

Tuesday, April 12

Toxoplasma gondii, cytomegalovirus and Treponema pallidum infection in pregnancy, what's new?

 

28/01/2015

Tuesday, June 23 - EDUW 25
Testing 1,25 Dihydroxyvitamin D: efficiency, automation, clinical need

Tuesday, June 23 - EDUW 23
How efficient and automated can be Serology and Stool testing?

17/04/2013

20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
45th Congress of SIBioC

Download DiaSorin workshops schedule & booth info

17/04/2013

20th IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine
45th Congress of SIBioC

Download DiaSorin workshops schedule & booth info

28/01/2013

DiaSorin S.p.A. is pleased to announce the launch of the LIAISON® ALDOSTERONE assay on its LIAISON® analyzers family.

22/10/2012

DiaSorin announces the introduction of an auto-dilution for LIAISON® XL murex HBsAg Quant assay, as a result of the company’s commitment to quality and continuous improvement of its products.

12/10/2012

DiaSorin announces the introduction of the new product in its portfolio, LIAISON® XL murex recHTLV-I/II assay, for the qualitative determination of antibodies to Human T-cell Lymphotropic Virus (HTLV) type I and type II (anti-HTLV-I and anti-HTLV-II) in human serum or plasma samples.

10/04/2012

DiaSorin S.p.A. is pleased to announce the launch on its LIAISON® platforms of the Measles IgM and Mumps IgM assays.
These assays use chemiluminescence immunoassay technology on the LIAISON® analyzer for the qualitative determination of IgM antibodies to measles and mumps viruses in human serum or plasma.

20/06/2011

DiaSorin announces the successful development of two new assays for the semi-quantitative determination of antibodies to measles and mumps viruses on the LIAISON® instrument: LIAISON® Measles IgG and LIAISON® Mumps IgG.

06/06/2011

DiaSorin announces the successful development of 2 new assays for detection of antibodies to Mycoplasma pneumoniae on the LIAISON® instrument: LIAISON®Mycoplasma pneumoniae IgG and LIAISON®Mycoplasma pneumoniae IgM.

14/02/2011

DiaSorin announces the release of the LIAISON® N-TACT® PTH II Assay for the determination of parathyroid hormone levels. The LIAISON® N-TACT® PTH II Assay is a chemiluminescent immunoassay for the quantitative determination of intact PTH in Serum and EDTA-plasma, offering excellent precision, accuracy and sensitivity. 

13/07/2010

DiaSorin releases the only fully automated third generation assay for the determination of parathyroid hormone levels. LIAISON® 1-84 PTH is a chemiluminescent immunoassay for the quantitative determination of 1-84 PTH in serum and EDTA-plasma, without cross-reactivity with the 7-84 PTH fragment.

08/03/2010

DiaSorin S.p.A. has announced the successful development of 2 new assays for detection of antibodies to Parvovirus B19 on the LIAISON® instrument: LIAISON® Biotrin Parvovirus B19 IgG and IgM.

05/03/2010

The LIAISON® Calcitonin II Gen shows improved discrimination at low end when compared to the old assay. In addition, out of a population of 267 apparently healthy subjects, selected by normal levels of fT4, TSH and autoantibodies to Thyroglobulin, 98% of all values are below 10 pg/mL.

08/07/2008

LIAISON® HSV-1 Type Specific IgG is an indirect chemiluminescence immunoassay (CLlA) for the qualitative determination of specific IgG antibodies to Herpes simplex virus Type 1 (HSV-1) in human serum.
HSV-1 and HSV-2 IgG assays on LIAISON®, based on recombinant gG1 and gG2 antigens, respectively allow accurate and type-specific detection of IgG antibodies to Herpes simplex virus types 1 and 2. LIAISON® HSV-1/2 IgM completes the Herpes serology line on LIAISON®.
LIAISON® HSV-1 Type Specific IgG